Your browser doesn't support javascript.
loading
Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy.
Crespo, James; Sun, Hongxia; Wu, Jimin; Ding, Qing-Qing; Tang, Guilin; Robinson, Melissa K; Chen, Hui; Sahin, Aysegul A; Lim, Bora.
Afiliación
  • Crespo J; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Sun H; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Wu J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Ding QQ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Tang G; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Robinson MK; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Chen H; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Sahin AA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
  • Lim B; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
PLoS One ; 15(11): e0241775, 2020.
Article en En | MEDLINE | ID: mdl-33180796

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 Tipo de estudio: Guideline / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 Tipo de estudio: Guideline / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos